News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Major Drugmakers Like AstraZeneca PLC (AZN), GlaxoSmithKline (GSK). And Johnson & Johnson (JNJ) Link Up With Academia In Huge $27 Million UK Dementia Project


6/20/2014 6:41:31 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - Drugmakers are linking with eight British universities in a 16 million-pound ($27 million) public-private partnership to speed up research into dementia by studying data from 2 million people in the world's largest such project.

The new UK Dementias Research Platform will investigate the causes of dementia by tracking volunteers, aged 50 and over, who are taking part in existing population studies such as UK Biobank and the Million Women Study.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at News Release


comments powered by Disqus
   
Dementia

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES